Guillain Barre Syndrome – ANX005-GBS-05

Participate in a New Guillain‑Barré Syndrome Study

Profound Research is enrolling a Guillain-Barre Syndrome (GBS) study that is assessing an investigational medication to see how the drug interacts with the body and if it is effective.

To be eligible to participate, you must:

• Be 18-85 years of age
• Have a diagnosis of GBS
• Have GBS-related weakness no more than 10 days prior to start of study

Additional criteria apply.

Qualified participants will receive:

• Study-related care and study medication at no cost
• Financial compensation for time and travel expenses

See if this study is a good fit for you.